Penumbra Inc Stock News

Related Stocks: ARGX , MGNX , CUTR , RNA , FULC , ITOS , TMO , PEN , TNYA , SGHT , AADI , RCOR , PTGX , MDXG , CSTL , AGEN , ABUS , QDEL , TRIL , CHAQ , BCTG , ITMR , RACA ,

ALAMEDA, Calif., Dec. 22, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022.

ALAMEDA, Calif., Dec. 22, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 40th Annual J.P.

State of New Jersey Common Pension Fund D cut its position in shares of Penumbra, Inc. (NYSE:PEN) by 1.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,684 shares of the companys stock after selling 236 shares during the period. State []

Zacks Investment Research lowered shares of Penumbra (NYSE:PEN) from a hold rating to a sell rating in a research report released on Tuesday, Zacks.com reports. According to Zacks, Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The companys portfolio of products primarily addresses neuro and peripheral vascular medical []

The Embolization Products Market research report includes the competitive landscape that involves leading companies and adopting strategies to introduce new products, announce partnerships, and collaborate to contribute to market growth. Moreover, the report elaborates on numerous customers journeys related to

Financial Counselors Inc. trimmed its stake in Penumbra, Inc. (NYSE:PEN) by 5.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 800 shares of the companys stock after selling 50 shares during the quarter. Financial Counselors Inc.s holdings in Penumbra were worth $213,000 []

Aegon Asset Management UK PLC increased its holdings in shares of Penumbra, Inc. (NYSE:PEN) by 6.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 31,099 shares of the companys stock after acquiring an additional 1,764 shares during the period. Aegon Asset Management UK PLC []

This Embolization Devices market report breaks down the market into segments and sub-segments. With this market analysis, managing the outline of the industries gets simple. This Embolization Devices market report also assists in making informed decisions by giving unique industry

Crossmark Global Holdings Inc. lowered its position in Penumbra, Inc. (NYSE:PEN) by 4.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,092 shares of the companys stock after selling 170 shares during the period. Crossmark Global Holdings Inc.s holdings in Penumbra []

Penumbra (NYSE:PEN) and G Medical Innovations (NASDAQ:GMVD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of recent ratings and price targets for Penumbra and G []

Penumbra, Inc. (NYSE:PEN) EVP Johanna Roberts sold 1,750 shares of Penumbra stock in a transaction dated Wednesday, December 1st. The shares were sold at an average price of $246.97, for a total value of $432,197.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this []

Shares of Penumbra, Inc. (NYSE:PEN) have earned an average rating of Buy from the eight research firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price target among brokerages that have []

Vivid Financial Management Inc. lowered its stake in Penumbra, Inc. (NYSE:PEN) by 31.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 903 shares of the companys stock after selling 405 shares during the quarter. Vivid Financial Management Inc.s holdings in Penumbra were []

Polaris Wealth Advisory Group LLC increased its stake in Penumbra, Inc. (NYSE:PEN) by 46.3% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,072 shares of the company’s stock after purchasing an additional 1,604 shares during the quarter. Polaris Wealth Advisory Group LLC’s holdings in […]